I was wondering if folks had any advice on the simplest way to generate a principal component analysis or MDS plot with Cufflinks output. I could group all my Cufflinks output into a data matrix and then try to visualize it but I was wondering if there was a built in way in R (perhaps through a tool or package like cummerbun) Thanks -Rich
Unconfigured Ad
Collapse
X
-
Hi Rich,Originally posted by greener View PostI was wondering if folks had any advice on the simplest way to generate a principal component analysis or MDS plot with Cufflinks output. I could group all my Cufflinks output into a data matrix and then try to visualize it but I was wondering if there was a built in way in R (perhaps through a tool or package like cummerbun) Thanks -Rich
Awesome idea, and one that can be very easily implemented with cummeRbund. If you run a cuffdiff on all of your samples, cummeRbund will take care of aggregating the information into a SQLite db behind the scenes. The generation of the FPKM matrix is very simple once this is complete:
etc,etc,...Code:>library(cummeRbund) >cuff<-readCufflinks() >allGeneFPKMs<-fpkmMatrix(genes(cuff)) #You can of course use the transpose if you want samples instead of genes >genes.pca<-prcomp(allGeneFPKMs) >biplot(genes.pca) >allIsoformFPKMs<-fpkmMatrix(isoforms(cuff)) >isoforms.pca<-prcomp(allIsoformFPKMs)
Please let me know how this works out for you. It may be something that I would like to integrate into cummeRbund for the future.
Cheers,
Loyal
-
-
That's great, the plot generated by the MDSplot command is very useful. It would be nice to be able to color samples by arbitrary experimental conditions, for example, to be able to make all replicates of one sample the same color.
It is easy enough to run each command in the MDSplot function manually and supply a different "names" vector to the geom color option:
customnames<- c("Wildtype", "Wildtype", "Wildtype", "Mutant", "Mutant", "Mutant")
p <- p + geom_point(aes(x=M1,y=M2,color=customnames)) + geom_text(aes(x=M1,y=M2,label=names,color=customnames)) + theme_bw()
But it would be nice to have that capability built into the function.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
Comment